Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis

Jean Pierre Vartanian, Michel Henry, Agnès Marchio, Rodolphe Suspène, Marie Ming Aynaud, Denise Guétard, Minerva Cervantes-Gonzalez, Carlo Battiston, Vincenzo Mazzaferro, Pascal Pineau, Anne Dejean, Simon Wain-Hobson

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

DNA viruses, retroviruses and hepadnaviruses, such as hepatitis B virus (HBV), are vulnerable to genetic editing of single stranded DNA by host cell APOBEC3 (A3) cytidine deaminases. At least three A3 genes are up regulated by interferon-α in human hepatocytes while ectopic expression of activation induced deaminase (AICDA), an A3 paralog, has been noted in a variety of chronic inflammatory syndromes including hepatitis C virus infection. Yet virtually all studies of HBV editing have confined themselves to analyses of virions from culture supernatants or serum where the frequency of edited genomes is generally low (le;10-2). We decided to look at the nature and frequency of HBV editing in cirrhotic samples taken during removal of a primary hepatocellular carcinoma. Forty-one cirrhotic tissue samples (10 alcoholic, 10 HBV+, 11 HBV+HCV+ and 10 HCV+) as well as 4 normal livers were studied. Compared to normal liver, 5/7 APOBEC3 genes were significantly up regulated in the order: HCV±HBV>HBV>alcoholic cirrhosis. A3C and A3D were up regulated for all groups while the interferon inducible A3G was over expressed in virus associated cirrhosis, as was AICDA in ~50% of these HBV/HCV samples. While AICDA can indeed edit HBV DNA ex vivo, A3G is the dominant deaminase in vivo with up to 35% of HBV genomes being edited. Despite these highly deleterious mutant spectra, a small fraction of genomes survive and contribute to loss of HBeAg antigenemia and possibly HBsAg immune escape. In conclusion, the cytokine storm associated with chronic inflammatory responses to HBV and HCV clearly up regulates a number of A3 genes with A3G clearly being a major restriction factor for HBV. Although the mutant spectrum resulting from A3 editing is highly deleterious, a very small part, notably the lightly edited genomes, might help the virus evolve and even escape immune responses.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalPLoS Pathogens
Volume6
Issue number5
DOIs
Publication statusPublished - May 2010

Fingerprint

Viral DNA
Hepatitis B
Hepatitis B virus
Fibrosis
Genome
Interferons
Hepadnaviridae
Cytidine Deaminase
Genes
Alcoholic Hepatitis
Viruses
Alcoholic Liver Cirrhosis
DNA Viruses
Hepatitis B e Antigens
Single-Stranded DNA
Liver
Virus Diseases
Retroviridae
Hepatitis B Surface Antigens
Hepacivirus

ASJC Scopus subject areas

  • Microbiology
  • Parasitology
  • Virology
  • Immunology
  • Genetics
  • Molecular Biology

Cite this

Vartanian, J. P., Henry, M., Marchio, A., Suspène, R., Aynaud, M. M., Guétard, D., ... Wain-Hobson, S. (2010). Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathogens, 6(5), 1-9. https://doi.org/10.1371/journal.ppat.1000928

Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. / Vartanian, Jean Pierre; Henry, Michel; Marchio, Agnès; Suspène, Rodolphe; Aynaud, Marie Ming; Guétard, Denise; Cervantes-Gonzalez, Minerva; Battiston, Carlo; Mazzaferro, Vincenzo; Pineau, Pascal; Dejean, Anne; Wain-Hobson, Simon.

In: PLoS Pathogens, Vol. 6, No. 5, 05.2010, p. 1-9.

Research output: Contribution to journalArticle

Vartanian, JP, Henry, M, Marchio, A, Suspène, R, Aynaud, MM, Guétard, D, Cervantes-Gonzalez, M, Battiston, C, Mazzaferro, V, Pineau, P, Dejean, A & Wain-Hobson, S 2010, 'Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis', PLoS Pathogens, vol. 6, no. 5, pp. 1-9. https://doi.org/10.1371/journal.ppat.1000928
Vartanian JP, Henry M, Marchio A, Suspène R, Aynaud MM, Guétard D et al. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathogens. 2010 May;6(5):1-9. https://doi.org/10.1371/journal.ppat.1000928
Vartanian, Jean Pierre ; Henry, Michel ; Marchio, Agnès ; Suspène, Rodolphe ; Aynaud, Marie Ming ; Guétard, Denise ; Cervantes-Gonzalez, Minerva ; Battiston, Carlo ; Mazzaferro, Vincenzo ; Pineau, Pascal ; Dejean, Anne ; Wain-Hobson, Simon. / Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. In: PLoS Pathogens. 2010 ; Vol. 6, No. 5. pp. 1-9.
@article{fdfdd851d3a9468c961cbc1c8b417bca,
title = "Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis",
abstract = "DNA viruses, retroviruses and hepadnaviruses, such as hepatitis B virus (HBV), are vulnerable to genetic editing of single stranded DNA by host cell APOBEC3 (A3) cytidine deaminases. At least three A3 genes are up regulated by interferon-α in human hepatocytes while ectopic expression of activation induced deaminase (AICDA), an A3 paralog, has been noted in a variety of chronic inflammatory syndromes including hepatitis C virus infection. Yet virtually all studies of HBV editing have confined themselves to analyses of virions from culture supernatants or serum where the frequency of edited genomes is generally low (le;10-2). We decided to look at the nature and frequency of HBV editing in cirrhotic samples taken during removal of a primary hepatocellular carcinoma. Forty-one cirrhotic tissue samples (10 alcoholic, 10 HBV+, 11 HBV+HCV+ and 10 HCV+) as well as 4 normal livers were studied. Compared to normal liver, 5/7 APOBEC3 genes were significantly up regulated in the order: HCV±HBV>HBV>alcoholic cirrhosis. A3C and A3D were up regulated for all groups while the interferon inducible A3G was over expressed in virus associated cirrhosis, as was AICDA in ~50{\%} of these HBV/HCV samples. While AICDA can indeed edit HBV DNA ex vivo, A3G is the dominant deaminase in vivo with up to 35{\%} of HBV genomes being edited. Despite these highly deleterious mutant spectra, a small fraction of genomes survive and contribute to loss of HBeAg antigenemia and possibly HBsAg immune escape. In conclusion, the cytokine storm associated with chronic inflammatory responses to HBV and HCV clearly up regulates a number of A3 genes with A3G clearly being a major restriction factor for HBV. Although the mutant spectrum resulting from A3 editing is highly deleterious, a very small part, notably the lightly edited genomes, might help the virus evolve and even escape immune responses.",
author = "Vartanian, {Jean Pierre} and Michel Henry and Agn{\`e}s Marchio and Rodolphe Susp{\`e}ne and Aynaud, {Marie Ming} and Denise Gu{\'e}tard and Minerva Cervantes-Gonzalez and Carlo Battiston and Vincenzo Mazzaferro and Pascal Pineau and Anne Dejean and Simon Wain-Hobson",
year = "2010",
month = "5",
doi = "10.1371/journal.ppat.1000928",
language = "English",
volume = "6",
pages = "1--9",
journal = "PLoS Pathogens",
issn = "1553-7366",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis

AU - Vartanian, Jean Pierre

AU - Henry, Michel

AU - Marchio, Agnès

AU - Suspène, Rodolphe

AU - Aynaud, Marie Ming

AU - Guétard, Denise

AU - Cervantes-Gonzalez, Minerva

AU - Battiston, Carlo

AU - Mazzaferro, Vincenzo

AU - Pineau, Pascal

AU - Dejean, Anne

AU - Wain-Hobson, Simon

PY - 2010/5

Y1 - 2010/5

N2 - DNA viruses, retroviruses and hepadnaviruses, such as hepatitis B virus (HBV), are vulnerable to genetic editing of single stranded DNA by host cell APOBEC3 (A3) cytidine deaminases. At least three A3 genes are up regulated by interferon-α in human hepatocytes while ectopic expression of activation induced deaminase (AICDA), an A3 paralog, has been noted in a variety of chronic inflammatory syndromes including hepatitis C virus infection. Yet virtually all studies of HBV editing have confined themselves to analyses of virions from culture supernatants or serum where the frequency of edited genomes is generally low (le;10-2). We decided to look at the nature and frequency of HBV editing in cirrhotic samples taken during removal of a primary hepatocellular carcinoma. Forty-one cirrhotic tissue samples (10 alcoholic, 10 HBV+, 11 HBV+HCV+ and 10 HCV+) as well as 4 normal livers were studied. Compared to normal liver, 5/7 APOBEC3 genes were significantly up regulated in the order: HCV±HBV>HBV>alcoholic cirrhosis. A3C and A3D were up regulated for all groups while the interferon inducible A3G was over expressed in virus associated cirrhosis, as was AICDA in ~50% of these HBV/HCV samples. While AICDA can indeed edit HBV DNA ex vivo, A3G is the dominant deaminase in vivo with up to 35% of HBV genomes being edited. Despite these highly deleterious mutant spectra, a small fraction of genomes survive and contribute to loss of HBeAg antigenemia and possibly HBsAg immune escape. In conclusion, the cytokine storm associated with chronic inflammatory responses to HBV and HCV clearly up regulates a number of A3 genes with A3G clearly being a major restriction factor for HBV. Although the mutant spectrum resulting from A3 editing is highly deleterious, a very small part, notably the lightly edited genomes, might help the virus evolve and even escape immune responses.

AB - DNA viruses, retroviruses and hepadnaviruses, such as hepatitis B virus (HBV), are vulnerable to genetic editing of single stranded DNA by host cell APOBEC3 (A3) cytidine deaminases. At least three A3 genes are up regulated by interferon-α in human hepatocytes while ectopic expression of activation induced deaminase (AICDA), an A3 paralog, has been noted in a variety of chronic inflammatory syndromes including hepatitis C virus infection. Yet virtually all studies of HBV editing have confined themselves to analyses of virions from culture supernatants or serum where the frequency of edited genomes is generally low (le;10-2). We decided to look at the nature and frequency of HBV editing in cirrhotic samples taken during removal of a primary hepatocellular carcinoma. Forty-one cirrhotic tissue samples (10 alcoholic, 10 HBV+, 11 HBV+HCV+ and 10 HCV+) as well as 4 normal livers were studied. Compared to normal liver, 5/7 APOBEC3 genes were significantly up regulated in the order: HCV±HBV>HBV>alcoholic cirrhosis. A3C and A3D were up regulated for all groups while the interferon inducible A3G was over expressed in virus associated cirrhosis, as was AICDA in ~50% of these HBV/HCV samples. While AICDA can indeed edit HBV DNA ex vivo, A3G is the dominant deaminase in vivo with up to 35% of HBV genomes being edited. Despite these highly deleterious mutant spectra, a small fraction of genomes survive and contribute to loss of HBeAg antigenemia and possibly HBsAg immune escape. In conclusion, the cytokine storm associated with chronic inflammatory responses to HBV and HCV clearly up regulates a number of A3 genes with A3G clearly being a major restriction factor for HBV. Although the mutant spectrum resulting from A3 editing is highly deleterious, a very small part, notably the lightly edited genomes, might help the virus evolve and even escape immune responses.

UR - http://www.scopus.com/inward/record.url?scp=77954074544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954074544&partnerID=8YFLogxK

U2 - 10.1371/journal.ppat.1000928

DO - 10.1371/journal.ppat.1000928

M3 - Article

AN - SCOPUS:77954074544

VL - 6

SP - 1

EP - 9

JO - PLoS Pathogens

JF - PLoS Pathogens

SN - 1553-7366

IS - 5

ER -